bladder cancer

News

Seattle Genetics and Astellas file bladder cancer drug in US

Seattle Genetics and Astellas have filed their antibody-drug conjugate enfortumab vedotin with the US drug regulator for advanced bladder cancer, after failure of chemotherapy and immunothe

Oncology

Cold virus strain could be used as therapy for bladder cance...

A strain of the common cold virus can infect and kill bladder cancer cells, according to a small study, raising hopes of a potential new therapy.

News

Astellas/Seattle Genetics target advanced bladder cancer wit...

Roche and Merck & Co have got their respective immunotherapies Tecentriq and Keytruda approved in bladder cancer – but the problem of low response rates remains. At the ASCO an

News

J&J gets US okay for first targeted bladder cancer drug

Johnson & Johnson’s Balversa has become the first targeted therapy for bladder cancer after an FDA approval at the tail end of last week for patients with mutations in the FGFR gene.

News

BMS and Infinity trial immunotherapy combo in bladder cancer

Bristol-Myers Squibb has broadened a collaboration with Infinity Pharmaceuticals as it seeks to find combinations that boost the potency of its cancer immunotherapy, Opdivo.

News